Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Submitted by
admin
on July 4, 2011 - 9:20am
Source:
Seeking Alpha
News Tags:
Dendreon
prostate cancer
cancer immunotherapy
Cel-Sci
Cell Therapeutics
ImmunoCellular
Keryx
Teva Pharmaceuticals
Oncothyreon
Headline:
Dendreon Leads the 'Now Generation' For Cancer Immunotherapeutic Treatment
Do Not Allow Advertisers to Use My Personal information